CN101998856A - 锌/甲氧苄啶结合治疗 - Google Patents

锌/甲氧苄啶结合治疗 Download PDF

Info

Publication number
CN101998856A
CN101998856A CN2009801074137A CN200980107413A CN101998856A CN 101998856 A CN101998856 A CN 101998856A CN 2009801074137 A CN2009801074137 A CN 2009801074137A CN 200980107413 A CN200980107413 A CN 200980107413A CN 101998856 A CN101998856 A CN 101998856A
Authority
CN
China
Prior art keywords
zinc
trimethoprim
compositions
viral infection
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801074137A
Other languages
English (en)
Chinese (zh)
Inventor
马格蒂·埃尔-哈巴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN101998856A publication Critical patent/CN101998856A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2009801074137A 2008-03-03 2009-02-27 锌/甲氧苄啶结合治疗 Pending CN101998856A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0803948.9A GB0803948D0 (en) 2008-03-03 2008-03-03 Combination therapy
GB0803948.9 2008-03-03
PCT/EP2009/052394 WO2009109531A2 (en) 2008-03-03 2009-02-27 Combination therapy

Publications (1)

Publication Number Publication Date
CN101998856A true CN101998856A (zh) 2011-03-30

Family

ID=39315874

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801074137A Pending CN101998856A (zh) 2008-03-03 2009-02-27 锌/甲氧苄啶结合治疗

Country Status (11)

Country Link
US (1) US10045984B2 (https=)
EP (1) EP2257292B1 (https=)
JP (1) JP5587215B2 (https=)
CN (1) CN101998856A (https=)
CA (1) CA2754281C (https=)
CY (1) CY1115555T1 (https=)
DK (1) DK2257292T3 (https=)
ES (1) ES2507570T3 (https=)
GB (1) GB0803948D0 (https=)
PT (1) PT2257292E (https=)
WO (1) WO2009109531A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2740657C1 (ru) * 2020-05-15 2021-01-19 Общество С Ограниченной Ответственностью "Промомед Рус" Противовирусная композиция
NL2028566B1 (nl) * 2021-06-29 2023-01-09 Simons Care Innovation Group B V Een zinkzout huidpleister en werkwijzen
JP7287730B2 (ja) * 2021-10-12 2023-06-06 ローバル株式会社 ウイルスを不活化可能な高濃度亜鉛末塗料

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125610A (en) * 1977-07-27 1978-11-14 Bristol-Myers Company Antibacterial compositions
US5637311A (en) * 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
B. SIMO: "《Interactions of metal ions with a 2,4-diaminopyrimidine derivative (trimethoprim) Antibacterial studies》", 《JOURNAL OF INORGANIC BIOCHEMISTRY》 *

Also Published As

Publication number Publication date
US10045984B2 (en) 2018-08-14
ES2507570T3 (es) 2014-10-15
GB0803948D0 (en) 2008-04-09
EP2257292A2 (en) 2010-12-08
DK2257292T3 (da) 2014-09-29
PT2257292E (pt) 2014-10-22
US20110045070A1 (en) 2011-02-24
EP2257292B1 (en) 2014-07-16
WO2009109531A3 (en) 2009-11-12
JP5587215B2 (ja) 2014-09-10
CA2754281A1 (en) 2009-09-11
CY1115555T1 (el) 2017-01-04
CA2754281C (en) 2016-12-06
JP2011513356A (ja) 2011-04-28
WO2009109531A2 (en) 2009-09-11

Similar Documents

Publication Publication Date Title
JP7019727B2 (ja) インフルエンザの治療方法
AP1163A (en) Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases.
TWI658829B (zh) 用於抑制磷酸鹽輸送之nhe3結合化合物及方法
JP2007332141A (ja)
US9662360B2 (en) Treatment of herpes, pseudomonas, staph, and hepatitis
CN102448438A (zh) 抗流行性感冒调配物及方法
JP2007291067A (ja) 医薬組成物
CN102652017A (zh) 协同抗病毒组合物及其应用
WO2020241759A1 (ja) インフルエンザウイルス感染症またはコロナウイルス感染症の予防および/または治療剤
CN104840467A (zh) 五环三萜类肠道病毒ev71抑制剂、其药物组合物及医药用途
Jimenez et al. Dendrimers as topical microbicides with activity against HIV
CN101998856A (zh) 锌/甲氧苄啶结合治疗
US6500808B2 (en) Anti-viral composition
WO2016036273A1 (ru) Лекарственное средство для профилактики и лечения заболеваний дыхательных путей
JPH01132526A (ja) 薬剤組成物
WO2013066208A2 (ru) Фармацевтическая композиция на основе наномицелл, содержащих эпигаллокатехингаллат, и ее применение для лечения атопического дерматита, болезни крона, аденомиоза и гиперпластических заболеваний предстательной железы
CN101884651A (zh) 山香圆叶水提取物及其制备方法和用途
WO2006105725A1 (en) A combination of luteolin and one of pt chemotherapeutics
WO2021242751A1 (en) Compositions and methods for treating sars-cov-2
WO2006076863A1 (en) The synergistically pharmaceutical composition for inhibiting tumor
CN114377018B (zh) 硝呋莫司在制备抗流感病毒药物中的应用
JP2007291072A (ja) 医薬組成物
Rong et al. Repurposing Niclosamide for COVID-19: Synergistic Strategies of Nanotechnology and Novel Materials to Enhance Antiviral Efficacy
Gupta et al. Emerging bioactive antiviral drugs in the light of epidemics
US20240009214A1 (en) Method of Treating Viral Infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20110330